Latest News

A law authorizing the cultivation of medical cannabis was passed in 2020, but it was only recently that the law was implemented with the creation of an agency responsible for overseeing this new sector: the Cannabis Cultivation Management Committee. Government authorities hope that this new industry will help support the country's economy.

The Spanish government has passed a decree authorizing the medical use of THC-based drugs, prescribed only by hospital doctors. Priority beneficiaries will be patients suffering from severe epilepsy, spasticity related to multiple sclerosis, nausea due to chemotherapy, or chronic pain resistant to conventional treatments.

The European Union launches Cannapol, a tool developed by the European Union Drugs Agency (EUDA) to support Member States in implementing policies on recreational cannabis.

In a post on Truth Social, US President Donald Trump recognizes that CBD helps slow the progression of certain diseases and is an alternative to medication for the elderly. This is his strongest statement in favor of cannabis-related products since he took office in January 2025.

According to a recent report by the New York State Office of Cannabis Management, cumulative sales since legalization now exceed $2 billion, with nearly $1 billion generated since the beginning of the year.

Analytical chemists at Stellenbosch University have identified the presence of flavoalkaloids in cannabis leaves, a rare class of phenolic compounds. Phenolics—and flavonoids in particular—are attracting considerable interest in the pharmaceutical industry due to their recognized antioxidant, anti-inflammatory, and anti-carcinogenic properties.

Between 2021 and 2023, cannabis use among Americans over the age of 65 jumped by 46%. According to a study published in the medical journal JAMA Internal Medicine, there has also been a significant increase in the number of users from high-income households in this age group.

Costa Ricans can now buy medical cannabis in pharmacies, on presentation of a prescription for conditions such as cancer, fibromyalgia or epilepsy.

Cannabis sales set a new record in April 2025, reaching almost $470 million. Statistics Canada also revised previous months' figures upwards, bringing February sales to $456.4 million and March sales to $462.5 million.

In the first academic publication since the Swiss pilot trials, researchers have compared the effects of a legal supply of cannabis with those of an illegal supply, and found a reduction in problematic use among those with legal access to cannabis.

As president of AQIC, I would like to express my willingness to work with your team and your ministers to ensure that our sector reaches its full potential, to the benefit of public health and safety, the environment and the Canadian economy. Our citizens support us. A recent poll shows that a majority want concrete action from the federal government to support our industry. Together, let's work for the health and safety of Canadians, and take advantage of the hemp and cannabis industries to make them powerful levers of prosperity, equity and economic sovereignty for Canada.

Researchers at the Whole Health Oncology Institute, in collaboration with the Chopra Foundation in the USA, have carried out a meta-analysis of thousands of studies devoted to medical cannabis. Their work reveals overwhelming scientific support for the potential of cannabis not only to relieve cancer-related symptoms, but also to slow, or even counteract, the progression of the disease itself.